July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
A Non-Invasive Physical Biomarker for Evaluation of Corneal Endothelial Cells
Author Affiliations & Notes
  • Hiroshi Tanaka
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, KYOTO, Japan
  • Akihisa Yamamoto
    Center for Integrative Medicine and Physics, Advanced Study, Japan
  • Munetoyo Toda
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, KYOTO, Japan
  • Chie Sotozono
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, KYOTO, Japan
  • Junji Hamuro
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, KYOTO, Japan
  • Shigeru Kinoshita
    Frontier Medical Science and Technology for Ophtalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan
  • Morio Ueno
    Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, KYOTO, Japan
  • Motomu Tanaka
    Center for Integrative Medicine and Physics, Advanced Study, Japan
    Physical Chemistry of Biosystems, Physical Chemistry, Germany
  • Footnotes
    Commercial Relationships   Hiroshi Tanaka, None; Akihisa Yamamoto, None; Munetoyo Toda, None; Chie Sotozono, None; Junji Hamuro, None; Shigeru Kinoshita, None; Morio Ueno, None; Motomu Tanaka, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 2156. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hiroshi Tanaka, Akihisa Yamamoto, Munetoyo Toda, Chie Sotozono, Junji Hamuro, Shigeru Kinoshita, Morio Ueno, Motomu Tanaka; A Non-Invasive Physical Biomarker for Evaluation of Corneal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2019;60(9):2156. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Corneal endothelial cell (CEC) injection therapy is a novel method for the treatment of bullous keratopathy, in which cultured donor CECs supplemented with rho-associated protein kinase (ROCK) inhibitor are injected into the anterior chamber and engrafted (Kinoshita S, et al., N Engl J Med. 2018;378(11):995-1003), and it allows for the treatment of numerous patients via a novel cell culturing method with an expansion of CEC proliferation from one donor cornea. Currently, the primary methods used for the evaluation of cells pre surgery, such as the identification of cell surface antigens and examination by immunostaining, requires a certain number of cells. In this study, we investigated a method to evaluate cells noninvasively by using a physical method for image analysis of cultured CECs before surgery.

Methods : In the corneal endothelial injection example performed as a clinical study at Kyoto Prefectural University of Medicine from December 2013 to September 2015, a binarized image was obtained from the preoperative cultured cell image in the flask (n = 8) and we created and calculated the spring constant between cells on the assumption that the cells are connected by springs. We examined the correlation between the value and the ratio (χCD44(–)) of cell surface antigen [CD44 (-)] that secured the cell function.

Results : The spring constant was the minimum value, the maximum value was 0.0048 µm–2, 0.052 µm–2, the minimum value of χCD44(–), the maximum value was 0.1%, 99.2%. Their linear correlation coefficient strongly correlated with r2= 0.86. In the spring constant, the images with good values showed clearer peaks, thus allowing the interaction between nonadjacent cells to be confirmed.

Conclusions : Evaluation of cultured CECs using physiological method in cell injection therapy had a strong correlation coefficient with conventional biological cell function-guaranteed examinations and could evaluate cells noninvasively. Furthermore, interaction between nonadjacent cells could be confirmed, and there is a possibility of evaluating the healthiness of the tissue.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×